<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37629143</PMID><DateCompleted><Year>2023</Year><Month>08</Month><Day>28</Day></DateCompleted><DateRevised><Year>2024</Year><Month>10</Month><Day>07</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1422-0067</ISSN><JournalIssue CitedMedium="Internet"><Volume>24</Volume><Issue>16</Issue><PubDate><Year>2023</Year><Month>Aug</Month><Day>19</Day></PubDate></JournalIssue><Title>International journal of molecular sciences</Title><ISOAbbreviation>Int J Mol Sci</ISOAbbreviation></Journal><ArticleTitle>SARS-CoV-2 Reinfections and Long COVID in the Post-Omicron Phase of the Pandemic.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">12962</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/ijms241612962</ELocationID><Abstract><AbstractText>We are reviewing the current state of knowledge on the virological and immunological correlates of long COVID, focusing on recent evidence for the possible association between the increasing number of SARS-CoV-2 reinfections and the parallel pandemic of long COVID. The severity of reinfections largely depends on the severity of the initial episode; in turn, this is determined both by a combination of genetic factors, particularly related to the innate immune response, and by the pathogenicity of the specific variant, especially its ability to infect and induce syncytia formation at the lower respiratory tract. The cumulative risk of long COVID as well as of various cardiac, pulmonary, or neurological complications increases proportionally to the number of SARS-CoV-2 infections, primarily in the elderly. Therefore, the number of long COVID cases is expected to remain high in the future. Reinfections apparently increase the likelihood of long COVID, but less so if they are mild or asymptomatic as in children and adolescents. Strategies to prevent SARS-CoV-2 reinfections are urgently needed, primarily among older adults who have a higher burden of comorbidities. Follow-up studies using an established case definition and precise diagnostic criteria of long COVID in people with or without reinfection may further elucidate the contribution of SARS-CoV-2 reinfections to the long COVID burden. Although accumulating evidence supports vaccination, both before and after the SARS-CoV-2 infection, as a preventive strategy to reduce the risk of long COVID, more robust comparative observational studies, including randomized trials, are needed to provide conclusive evidence of the effectiveness of vaccination in preventing or mitigating long COVID in all age groups. Thankfully, answers not only on the prevention, but also on treatment options and rates of recovery from long COVID are gradually starting to emerge.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Boufidou</LastName><ForeName>Fotini</ForeName><Initials>F</Initials><Identifier Source="ORCID">0000-0001-9691-9465</Identifier><AffiliationInfo><Affiliation>Neurochemistry and Biological Markers Unit, 1st Department of Neurology, Eginition Hospital, School of Medicine, National and Kapodistrian University of Athens, 11528 Athens, Greece.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Medi&#x107;</LastName><ForeName>Sne&#x17e;ana</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Epidemiology, Faculty of Medicine, University of Novi Sad, 21000 Novi Sad, Serbia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Disease Control and Prevention, Institute of Public Health of Vojvodina, 21000 Novi Sad, Serbia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lampropoulou</LastName><ForeName>Vicky</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Department of Microbiology, Medical School, National and Kapodistrian University of Athens, 11527 Athens, Greece.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Siafakas</LastName><ForeName>Nikolaos</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Clinical Microbiology, Attikon General Hospital, Medical School, National and Kapodistrian University of Athens, 12462 Athens, Greece.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tsakris</LastName><ForeName>Athanasios</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0003-0656-4715</Identifier><AffiliationInfo><Affiliation>Department of Microbiology, Medical School, National and Kapodistrian University of Athens, 11527 Athens, Greece.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Anastassopoulou</LastName><ForeName>Cleo</ForeName><Initials>C</Initials><Identifier Source="ORCID">0000-0001-7666-9198</Identifier><AffiliationInfo><Affiliation>Department of Microbiology, Medical School, National and Kapodistrian University of Athens, 11527 Athens, Greece.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>08</Month><Day>19</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Int J Mol Sci</MedlineTA><NlmUniqueID>101092791</NlmUniqueID><ISSNLinking>1422-0067</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="Y">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000084063" MajorTopicYN="N">Reinfection</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D058873" MajorTopicYN="N">Pandemics</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">ME/CFS</Keyword><Keyword MajorTopicYN="N">late sequelae</Keyword><Keyword MajorTopicYN="N">long COVID</Keyword><Keyword MajorTopicYN="N">long-haul COVID</Keyword><Keyword MajorTopicYN="N">pediatric long COVID</Keyword><Keyword MajorTopicYN="N">post-acute sequelae of SARS-CoV-2 infection (PASC)</Keyword><Keyword MajorTopicYN="N">reinfection severity</Keyword><Keyword MajorTopicYN="N">vaccination benefits</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>7</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>8</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>8</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>8</Month><Day>28</Day><Hour>7</Hour><Minute>16</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>8</Month><Day>26</Day><Hour>10</Hour><Minute>46</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>8</Month><Day>26</Day><Hour>1</Hour><Minute>17</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>8</Month><Day>19</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37629143</ArticleId><ArticleId IdType="pmc">PMC10454552</ArticleId><ArticleId IdType="doi">10.3390/ijms241612962</ArticleId><ArticleId IdType="pii">ijms241612962</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>US Centers for Disease Control and Prevention  Long COVID or Post-COVID Conditions.  [(accessed on 29 June 2023)]; Available online:  https://www.cdc.gov/coronavirus/2019-ncov/long-term-effects/index.html.</Citation></Reference><Reference><Citation>Davis H.E., McCorkell L., Vogel J.M., Topol E.J. Long COVID: Major findings, mechanisms and recommendations. Nat. Rev. Microbiol. 2023;21:133&#x2013;146. doi: 10.1038/s41579-022-00846-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41579-022-00846-2</ArticleId><ArticleId IdType="pmc">PMC9839201</ArticleId><ArticleId IdType="pubmed">36639608</ArticleId></ArticleIdList></Reference><Reference><Citation>Thaweethai T., Jolley S.E., Karlson E.W., Levitan E.B., Levy B., McComsey G.A., McCorkell L., Nadkarni G.N., Parthasarathy S., Singh U., et al. Development of a Definition of Postacute Sequelae of SARS-CoV-2 Infection. JAMA. 2023;329:1934&#x2013;1946. doi: 10.1001/jama.2023.8823.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2023.8823</ArticleId><ArticleId IdType="pmc">PMC10214179</ArticleId><ArticleId IdType="pubmed">37278994</ArticleId></ArticleIdList></Reference><Reference><Citation>Gottlieb M., Spatz E.S., Yu H., E Wisk L., Elmore J.G., Gentile N.L., Hill M., Huebinger R.M., Idris A.H., Kean E.R., et al. Long COVID Clinical Phenotypes up to 6 Months after Infection Identified by Latent Class Analysis of Self-Reported Symptoms. Open Forum Infect. Dis. 2023;10:ofad277. doi: 10.1093/ofid/ofad277.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ofid/ofad277</ArticleId><ArticleId IdType="pmc">PMC10327879</ArticleId><ArticleId IdType="pubmed">37426952</ArticleId></ArticleIdList></Reference><Reference><Citation>World Health Organization  A Clinical Case Definition of Post COVID-19 Condition by a Delphi Consensus, 6 October 2021.  [(accessed on 29 June 2023)]; Available online:  https://www.who.int/publications/i/item/WHO-2019-nCoV-Post_COVID-19_condition-Clinical_case_definition-2021.1.</Citation></Reference><Reference><Citation>Maltezou H.C., Pavli A., Tsakris A. Post-COVID Syndrome: An Insight on Its Pathogenesis. Vaccines. 2021;9:497. doi: 10.3390/vaccines9050497.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/vaccines9050497</ArticleId><ArticleId IdType="pmc">PMC8151752</ArticleId><ArticleId IdType="pubmed">34066007</ArticleId></ArticleIdList></Reference><Reference><Citation>Proal A.D., VanElzakker M.B. Long COVID or Post-acute Sequelae of COVID-19 (PASC): An Overview of Biological Factors That May Contribute to Persistent Symptoms. Front. Microbiol. 2021;12:698169. doi: 10.3389/fmicb.2021.698169.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmicb.2021.698169</ArticleId><ArticleId IdType="pmc">PMC8260991</ArticleId><ArticleId IdType="pubmed">34248921</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen B., Julg B., Mohandas S., Bradfute S.B., Force R.M.P.T., Division of Infectious Diseases. Department of Medicine. Icahn School of Medicine at Mount Sinai. United States. Infectious Diseases Division et al. Viral persistence, reactivation, and mechanisms of long COVID. eLife. 2023;12:e86015. doi: 10.7554/eLife.86015.</Citation><ArticleIdList><ArticleId IdType="doi">10.7554/eLife.86015</ArticleId><ArticleId IdType="pmc">PMC10159620</ArticleId><ArticleId IdType="pubmed">37140960</ArticleId></ArticleIdList></Reference><Reference><Citation>Choutka J., Jansari V., Hornig M., Iwasaki A. Unexplained post-acute infection syndromes. Nat. Med. 2022;28:911&#x2013;923. doi: 10.1038/s41591-022-01810-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-022-01810-6</ArticleId><ArticleId IdType="pubmed">35585196</ArticleId></ArticleIdList></Reference><Reference><Citation>Patterson B.K., Francisco E.B., Yogendra R., Long E., Pise A., Rodrigues H., Hall E., Herrera M., Parikh P., Guevara-Coto J., et al. Persistence of SARS CoV-2 S1 Protein in CD16+ Monocytes in Post-Acute Sequelae of COVID-19 (PASC) up to 15 Months Post-Infection. Front. Immunol. 2022;12:746021. doi: 10.3389/fimmu.2021.746021.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.746021</ArticleId><ArticleId IdType="pmc">PMC8784688</ArticleId><ArticleId IdType="pubmed">35082777</ArticleId></ArticleIdList></Reference><Reference><Citation>Yao X.H., He Z.C., Li T.Y., Zhang H.R., Wang Y., Mou H., Guo Q., Yu S.C., Ding Y., Liu X., et al. Pathological evidence for residual SARS-CoV-2 in pulmonary tissues of a ready-for-discharge patient. Cell Res. 2020;30:541&#x2013;543. doi: 10.1038/s41422-020-0318-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41422-020-0318-5</ArticleId><ArticleId IdType="pmc">PMC7186763</ArticleId><ArticleId IdType="pubmed">32346074</ArticleId></ArticleIdList></Reference><Reference><Citation>Nienhold R., Ciani Y., Koelzer V.H., Tzankov A., Haslbauer J.D., Menter T., Schwab N., Henkel M., Frank A., Zsikla V., et al. Two distinct immunopathological profiles in autopsy lungs of COVID-19. Nat. Commun. 2020;11:5086. doi: 10.1038/s41467-020-18854-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-020-18854-2</ArticleId><ArticleId IdType="pmc">PMC7546638</ArticleId><ArticleId IdType="pubmed">33033248</ArticleId></ArticleIdList></Reference><Reference><Citation>Gupta A., Madhavan M.V., Sehgal K., Nair N., Mahajan S., Sehrawat T.S., Bikdeli B., Ahluwalia N., Ausiello J.C., Wan E.Y., et al. Extrapulmonary manifestations of COVID-19. Nat. Med. 2020;26:1017&#x2013;1032. doi: 10.1038/s41591-020-0968-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-020-0968-3</ArticleId><ArticleId IdType="pubmed">32651579</ArticleId></ArticleIdList></Reference><Reference><Citation>Puelles V.G., L&#xfc;tgehetmann M., Lindenmeyer M.T., Sperhake J.P., Wong M.N., Allweiss L., Chilla S., Heinemann A., Wanner N., Liu S., et al. Multiorgan and Renal Tropism of SARS-CoV-2. N. Engl. J. Med. 2020;383:590&#x2013;592. doi: 10.1056/NEJMc2011400.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMc2011400</ArticleId><ArticleId IdType="pmc">PMC7240771</ArticleId><ArticleId IdType="pubmed">32402155</ArticleId></ArticleIdList></Reference><Reference><Citation>Qi F., Qian S., Zhang S., Zhang Z. Single cell RNA sequencing of 13 human tissues identify cell types and receptors of human coronaviruses. Biochem. Biophys. Res. Commun. 2020;526:135&#x2013;140. doi: 10.1016/j.bbrc.2020.03.044.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbrc.2020.03.044</ArticleId><ArticleId IdType="pmc">PMC7156119</ArticleId><ArticleId IdType="pubmed">32199615</ArticleId></ArticleIdList></Reference><Reference><Citation>Swank Z., Senussi Y., Manickas-Hill Z., Yu X.G., Li J.Z., Alter G., Walt D.R. Persistent Circulating Severe Acute Respiratory Syndrome Coronavirus 2 Spike Is Associated with Post-acute Coronavirus Disease 2019 Sequelae. Clin. Infect. Dis. 2022;76:e487&#x2013;e490. doi: 10.1093/cid/ciac722.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciac722</ArticleId><ArticleId IdType="pmc">PMC10169416</ArticleId><ArticleId IdType="pubmed">36052466</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu Y., Guo C., Tang L., Hong Z., Zhou J., Dong X., Yin H., Xiao Q., Tang Y., Qu X., et al. Prolonged presence of SARS-CoV-2 viral RNA in faecal samples. Lancet Gastroenterol. Hepatol. 2020;5:434&#x2013;435. doi: 10.1016/S2468-1253(20)30083-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2468-1253(20)30083-2</ArticleId><ArticleId IdType="pmc">PMC7158584</ArticleId><ArticleId IdType="pubmed">32199469</ArticleId></ArticleIdList></Reference><Reference><Citation>Viszlayov&#xe1; D., Sojka M., Dobrodenkov&#xe1; S., Szab&#xf3; S., Bilec O., Turzov&#xe1; M., &#x10e;urina J., Baloghov&#xe1; B., Borb&#xe9;ly Z., Kr&#x161;&#xe1;k M. SARS-CoV-2 RNA in the cerebrospinal fluid of a patient with long COVID. Ther. Adv. Infect Dis. 2021;8:20499361211048572. doi: 10.1177/20499361211048572.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/20499361211048572</ArticleId><ArticleId IdType="pmc">PMC8511908</ArticleId><ArticleId IdType="pubmed">34659752</ArticleId></ArticleIdList></Reference><Reference><Citation>Tejerina F., Catalan P., Rodriguez-Grande C., Adan J., Rodriguez-Gonzalez C., Aldamiz T., Diez C., Perez L., Fanciulli C., de Viedma D.G., et al. Post-COVID-19 syndrome. SARS-CoV-2 RNA detection in plasma, stool, and urine in patients with persistent symptoms after COVID-19. BMC Infect. Dis. 2022;22:211. doi: 10.1186/s12879-022-07153-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12879-022-07153-4</ArticleId><ArticleId IdType="pmc">PMC8892394</ArticleId><ArticleId IdType="pubmed">35240997</ArticleId></ArticleIdList></Reference><Reference><Citation>Goh D., Lim J.C.T., Ferna&#xed;ndez S.B., Joseph C.R., Gil Edwards S., Neo Z.W., Lee J.N., Caballero S.G., Lau M.C., Yeong J.P.S. Case report: Persistence of residual antigen and RNA of the SARS-CoV-2 virus in tissues of two patients with long COVID. Front. Immunol. 2022;13:939989. doi: 10.3389/fimmu.2022.939989.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2022.939989</ArticleId><ArticleId IdType="pmc">PMC9483160</ArticleId><ArticleId IdType="pubmed">36131932</ArticleId></ArticleIdList></Reference><Reference><Citation>Ceulemans L.J., Khan M., Yoo S.J., Zapiec B., Van Gerven L., Van Slambrouck J., Vanstapel A., Van Raemdonck D., Vos R., Wauters E., et al. Persistence of SARS-CoV-2 RNA in lung tissue after mild COVID-19. Lancet Respir. Med. 2021;9:e78&#x2013;e79. doi: 10.1016/S2213-2600(21)00240-X.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(21)00240-X</ArticleId><ArticleId IdType="pmc">PMC8189667</ArticleId><ArticleId IdType="pubmed">34118186</ArticleId></ArticleIdList></Reference><Reference><Citation>Gaebler C., Wang Z., Lorenzi J.C., Muecksch F., Finkin S., Tokuyama M., Cho A., Jankovic M., Schaefer-Babajew D., Oliveira T.Y., et al. Evolution of antibody immunity to SARS-CoV-2. Nature. 2021;591:639&#x2013;644. doi: 10.1038/s41586-021-03207-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-021-03207-w</ArticleId><ArticleId IdType="pmc">PMC8221082</ArticleId><ArticleId IdType="pubmed">33461210</ArticleId></ArticleIdList></Reference><Reference><Citation>Menuchin-Lasowski Y., Schreiber A., Lecanda A., Mecate-Zambrano A., Brunotte L., Psathaki O.E., Ludwig S., Rauen T., Sch&#xf6;ler H.R. SARS-CoV-2 infects and replicates in photoreceptor and retinal ganglion cells of human retinal organoids. Stem. Cell Rep. 2022;17:789&#x2013;803. doi: 10.1016/j.stemcr.2022.02.015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.stemcr.2022.02.015</ArticleId><ArticleId IdType="pmc">PMC8943915</ArticleId><ArticleId IdType="pubmed">35334213</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheung C.C.L., Goh D., Lim X., Tien T.Z., Lim J.C.T., Lee J.N., Tan B., Tay Z.E.A., Wan W.Y., Chen E.X., et al. Residual SARS-CoV-2 viral antigens detected in GI and hepatic tissues from five recovered patients with COVID-19. Gut. 2022;71:226&#x2013;229. doi: 10.1136/gutjnl-2021-324280.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/gutjnl-2021-324280</ArticleId><ArticleId IdType="pubmed">34083386</ArticleId></ArticleIdList></Reference><Reference><Citation>Kumata R., Ito J., Takahashi K., Suzuki T., Sato K. A tissue level atlas of the healthy human virome. BMC Biol. 2020;18:55. doi: 10.1186/s12915-020-00785-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12915-020-00785-5</ArticleId><ArticleId IdType="pmc">PMC7269688</ArticleId><ArticleId IdType="pubmed">32493363</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu R., Zhou Y., Cai L., Wang L., Han J., Yang X., Chen J., Ma C., Shen L. Co-reactivation of the human herpesvirus alpha subfamily (herpes simplex virus-1 and varicella zoster virus) in a critically ill patient with COVID-19. Br. J. Dermatol. 2020;183:1145&#x2013;1147. doi: 10.1111/bjd.19484.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/bjd.19484</ArticleId><ArticleId IdType="pmc">PMC7436688</ArticleId><ArticleId IdType="pubmed">32790074</ArticleId></ArticleIdList></Reference><Reference><Citation>Simula E.R., Manca M.A., Noli M., Jasemi S., Ruberto S., Uzzau S., Rubino S., Manca P., Sechi L.A. Increased Presence of Antibodies against Type I Interferons and Human Endogenous Retrovirus W in Intensive Care Unit COVID-19 Patients. Microbiol. Spectr. 2022;10:e0128022. doi: 10.1128/spectrum.01280-22.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/spectrum.01280-22</ArticleId><ArticleId IdType="pmc">PMC9430400</ArticleId><ArticleId IdType="pubmed">35852349</ArticleId></ArticleIdList></Reference><Reference><Citation>Temerozo J.R., Fintelman-Rodrigues N., dos Santos M.C., Hottz E.D., Sacramento C.Q., Silva A.d.P.D.d., Mandacaru S.C., Moraes E.C.d.S., Trugilho M.R.O., Gesto J.S.M., et al. Human endogenous retrovirus K in the respiratory tract is associated with COVID-19 physiopathology. Microbiome. 2022;10:65. doi: 10.1186/s40168-022-01260-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40168-022-01260-9</ArticleId><ArticleId IdType="pmc">PMC9024070</ArticleId><ArticleId IdType="pubmed">35459226</ArticleId></ArticleIdList></Reference><Reference><Citation>Klein J., Wood J., Jaycox J., Lu P., Dhodapkar R.M., Gehlhausen J.R., Tabachnikova A., Tabacof L., Malik A.A., Kamath K., et al. Distinguishing features of Long COVID identified through immune profiling. medRxiv. :2022. doi: 10.1101/2022.08.09.22278592.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2022.08.09.22278592</ArticleId><ArticleId IdType="pmc">PMC10620090</ArticleId><ArticleId IdType="pubmed">37748514</ArticleId></ArticleIdList></Reference><Reference><Citation>Schulthei&#xdf; C., Willscher E., Paschold L., Gottschick C., Klee B., Henkes S.-S., Bosurgi L., Dutzmann J., Sedding D., Frese T., et al. The IL-1&#x3b2;, IL-6, and TNF cytokine triad is associated with post-acute sequelae of COVID-19. Cell Rep. Med. 2022;3:100663. doi: 10.1016/j.xcrm.2022.100663.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.xcrm.2022.100663</ArticleId><ArticleId IdType="pmc">PMC9214726</ArticleId><ArticleId IdType="pubmed">35732153</ArticleId></ArticleIdList></Reference><Reference><Citation>Peluso M.J., Lu S., Tang A.F., Durstenfeld M.S., Ho H.-E., A Goldberg S., A Forman C., E Munter S., Hoh R., Tai V., et al. Markers of Immune Activation and Inflammation in Individuals with Postacute Sequelae of Severe Acute Respiratory Syndrome Coronavirus 2 Infection. J. Infect. Dis. 2021;224:1839&#x2013;1848. doi: 10.1093/infdis/jiab490.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/jiab490</ArticleId><ArticleId IdType="pmc">PMC8643408</ArticleId><ArticleId IdType="pubmed">34677601</ArticleId></ArticleIdList></Reference><Reference><Citation>Talla A., Vasaikar S.V., Lemos M.P., Moodie Z., Lee Pebworth M.P., Henderson K.E., Cohen K.W., Czartoski J.L., Lai L., Suthar M.S., et al. Longitudinal immune dynamics of mild COVID-19 define signatures of recovery and persistence. bioRxiv. 2021 doi: 10.1101/2021.05.26.442666.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2021.05.26.442666</ArticleId></ArticleIdList></Reference><Reference><Citation>Littlefield K.M., Watson R.O., Schneider J.M., Neff C.P., Yamada E., Zhang M., Campbell T.B., Falta M.T., Jolley S.E., Fontenot A.P., et al. SARS-CoV-2-specific T cells associate with inflammation and reduced lung function in pulmonary post-acute sequalae of SARS-CoV-2. PLoS Pathog. 2022;18:e1010359. doi: 10.1371/journal.ppat.1010359.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1010359</ArticleId><ArticleId IdType="pmc">PMC9176759</ArticleId><ArticleId IdType="pubmed">35617421</ArticleId></ArticleIdList></Reference><Reference><Citation>Phetsouphanh C., Darley D.R., Wilson D.B., Howe A., Munier C.M.L., Patel S.K., Juno J.A., Burrell L.M., Kent S.J., Dore G.J., et al. Immunological dysfunction persists for 8 months following initial mild-to-moderate SARS-CoV-2 infection. Nat. Immunol. 2022;23:210&#x2013;216. doi: 10.1038/s41590-021-01113-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41590-021-01113-x</ArticleId><ArticleId IdType="pubmed">35027728</ArticleId></ArticleIdList></Reference><Reference><Citation>Fern&#xe1;ndez-Casta&#xf1;eda A., Lu P., Geraghty A.C., Song E., Lee M.-H., Wood J., O&#x2019;dea M.R., Dutton S., Shamardani K., Nwangwu K., et al. Mild respiratory COVID can cause multi-lineage neural cell and myelin dysregulation. Cell. 2022;185:2452&#x2013;2468.e16. doi: 10.1016/j.cell.2022.06.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2022.06.008</ArticleId><ArticleId IdType="pmc">PMC9189143</ArticleId><ArticleId IdType="pubmed">35768006</ArticleId></ArticleIdList></Reference><Reference><Citation>Huber A.K., Giles D.A., Segal B.M., Irani D.N. An emerging role for eotaxins in neurodegenerative disease. Clin. Immunol. 2018;189:29&#x2013;33. doi: 10.1016/j.clim.2016.09.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clim.2016.09.010</ArticleId><ArticleId IdType="pubmed">27664933</ArticleId></ArticleIdList></Reference><Reference><Citation>Teixeira A.L., Gama C.S., Rocha N.P., Teixeira M.M. Revisiting the Role of Eotaxin-1/CCL11 in Psychiatric Disorders. Front. Psychiatry. 2018;9:241. doi: 10.3389/fpsyt.2018.00241.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fpsyt.2018.00241</ArticleId><ArticleId IdType="pmc">PMC6010544</ArticleId><ArticleId IdType="pubmed">29962972</ArticleId></ArticleIdList></Reference><Reference><Citation>Villeda S.A., Luo J., Mosher K.I., Zou B., Britschgi M., Bieri G., Stan T.M., Fainberg N., Ding Z., Eggel A., et al. The ageing systemic milieu negatively regulates neurogenesis and cognitive function. Nature. 2011;477:90&#x2013;94. doi: 10.1038/nature10357.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature10357</ArticleId><ArticleId IdType="pmc">PMC3170097</ArticleId><ArticleId IdType="pubmed">21886162</ArticleId></ArticleIdList></Reference><Reference><Citation>Glynne P., Tahmasebi N., Gant V., Gupta R. Long COVID following Mild SARS-CoV-2 Infection: Characteristic T Cell Alterations and Response to Antihistamines. J. Investig. Med. 2022;70:61&#x2013;67. doi: 10.1136/jim-2021-002051.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jim-2021-002051</ArticleId><ArticleId IdType="pmc">PMC8494538</ArticleId><ArticleId IdType="pubmed">34611034</ArticleId></ArticleIdList></Reference><Reference><Citation>Peluso M.J., Deitchman A.N., Torres L., Iyer N.S., Munter S.E., Nixon C.C., Donatelli J., Thanh C., Takahashi S., Hakim J., et al. Long-term SARS-CoV-2-specific immune and inflammatory responses in individuals recovering from COVID-19 with and without post-acute symptoms. Cell Rep. 2021;36:109518. doi: 10.1016/j.celrep.2021.109518.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2021.109518</ArticleId><ArticleId IdType="pmc">PMC8342976</ArticleId><ArticleId IdType="pubmed">34358460</ArticleId></ArticleIdList></Reference><Reference><Citation>Visvabharathy L., Hanson B.A., Orban Z.S., Lim P.H., Palacio N.M., Jimenez M., Clark J.R., Graham E.L., Liotta E.M., Tachas G., et al. T cell responses to SARS-CoV-2 in people with and without neurologic symptoms of long COVID. medRxiv. 2022 doi: 10.1101/2021.08.08.21261763.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2021.08.08.21261763</ArticleId></ArticleIdList></Reference><Reference><Citation>Su Y., Yuan D., Chen D.G., Ng R.H., Wang K., Choi J., Li S., Hong S., Zhang R., Xie J., et al. Multiple early factors anticipate post-acute COVID-19 sequelae. Cell. 2022;185:881&#x2013;895.e20. doi: 10.1016/j.cell.2022.01.014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2022.01.014</ArticleId><ArticleId IdType="pmc">PMC8786632</ArticleId><ArticleId IdType="pubmed">35216672</ArticleId></ArticleIdList></Reference><Reference><Citation>Bergamaschi L., Mescia F., Turner L., Hanson A.L., Kotagiri P., Dunmore B.J., Ruffieux H., De Sa A., Huhn O., Morgan M.D., et al. Longitudinal analysis reveals that delayed bystander CD8+ T cell activation and early immune pathology distinguish severe COVID-19 from mild disease. Immunity. 2021;54:1257&#x2013;1275.e8. doi: 10.1016/j.immuni.2021.05.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.immuni.2021.05.010</ArticleId><ArticleId IdType="pmc">PMC8125900</ArticleId><ArticleId IdType="pubmed">34051148</ArticleId></ArticleIdList></Reference><Reference><Citation>Augustin M., Schommers P., Stecher M., Dewald F., Gieselmann L., Gruell H., Horn C., Vanshylla K., Di Cristanziano V., Osebold L., et al. Post-COVID syndrome in non-hospitalised patients with COVID-19: A longitudinal prospective cohort study. Lancet Reg. Health-Eur. 2021;6:100122. doi: 10.1016/j.lanepe.2021.100122.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.lanepe.2021.100122</ArticleId><ArticleId IdType="pmc">PMC8129613</ArticleId><ArticleId IdType="pubmed">34027514</ArticleId></ArticleIdList></Reference><Reference><Citation>Garc&#xed;a-Abell&#xe1;n J., Padilla S., Fern&#xe1;ndez-Gonz&#xe1;lez M., Garc&#xed;a J.A., Agull&#xf3; V., Andreo M., Ruiz S., Galiana A., Guti&#xe9;rrez F., Masi&#xe1; M. Antibody Response to SARS-CoV-2 is Associated with Long-term Clinical Outcome in Patients with COVID-19: A Longitudinal Study. J. Clin. Immunol. 2021;41:1490&#x2013;1501. doi: 10.1007/s10875-021-01083-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10875-021-01083-7</ArticleId><ArticleId IdType="pmc">PMC8285689</ArticleId><ArticleId IdType="pubmed">34273064</ArticleId></ArticleIdList></Reference><Reference><Citation>Pereira C., Harris B.H.L., Di Giovannantonio M., Rosadas C., Short C.-E., Quinlan R., Sureda-Vives M., Fernandez N., Day-Weber I., Khan M., et al. The Association Between Antibody Response to Severe Acute Respiratory Syndrome Coronavirus 2 Infection and Post&#x2013;COVID-19 Syndrome in Healthcare Workers. J. Infect. Dis. 2021;223:1671&#x2013;1676. doi: 10.1093/infdis/jiab120.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/jiab120</ArticleId><ArticleId IdType="pmc">PMC7989400</ArticleId><ArticleId IdType="pubmed">33675366</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang E.Y., Mao T., Klein J., Dai Y., Huck J.D., Jaycox J.R., Liu F., Zhou T., Israelow B., Wong P., et al. Diverse Functional Autoantibodies in Patients with COVID-19. Nature. 2021;595:283&#x2013;288. doi: 10.1038/s41586-021-03631-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-021-03631-y</ArticleId><ArticleId IdType="pubmed">34010947</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang S.E., Feng A., Meng W., Apostolidis S.A., Mack E., Artandi M., Barman L., Bennett K., Chakraborty S., Chang I., et al. New-onset IgG autoantibodies in hospitalized patients with COVID-19. Nat. Commun. 2021;12:5417. doi: 10.1038/s41467-021-25509-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-021-25509-3</ArticleId><ArticleId IdType="pmc">PMC8440763</ArticleId><ArticleId IdType="pubmed">34521836</ArticleId></ArticleIdList></Reference><Reference><Citation>Woodruff M.C., Ramonell R.P., Haddad N.S., Anam F.A., Rudolph M.E., Walker T.A., Truong A.D., Dixit A.N., Han J.E., Cabrera-Mora M., et al. Dysregulated naive B cells and de novo autoreactivity in severe COVID-19. Nature. 2022;611:139&#x2013;147. doi: 10.1038/s41586-022-05273-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-022-05273-0</ArticleId><ArticleId IdType="pmc">PMC9630115</ArticleId><ArticleId IdType="pubmed">36044993</ArticleId></ArticleIdList></Reference><Reference><Citation>Arthur J.M., Forrest J.C., Boehme K.W., Kennedy J.L., Owens S., Herzog C., Liu J., Harville T.O. Development of ACE2 autoantibodies after SARS-CoV-2 infection. PLoS ONE. 2021;16:e0257016. doi: 10.1371/journal.pone.0257016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0257016</ArticleId><ArticleId IdType="pmc">PMC8415618</ArticleId><ArticleId IdType="pubmed">34478478</ArticleId></ArticleIdList></Reference><Reference><Citation>Wallukat G., Hohberger B., Wenzel K., F&#xfc;rst J., Schulze-Rothe S., Wallukat A., H&#xf6;nicke A.-S., M&#xfc;ller J. Functional autoantibodies against G-protein coupled receptors in patients with persistent Long-COVID-19 symptoms. J. Transl. Autoimmun. 2021;4:100100. doi: 10.1016/j.jtauto.2021.100100.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jtauto.2021.100100</ArticleId><ArticleId IdType="pmc">PMC8049853</ArticleId><ArticleId IdType="pubmed">33880442</ArticleId></ArticleIdList></Reference><Reference><Citation>Skiba M.A., Kruse A.C. Autoantibodies as Endogenous Modulators of GPCR Signaling. Trends Pharmacol. Sci. 2021;42:135&#x2013;150. doi: 10.1016/j.tips.2020.11.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tips.2020.11.013</ArticleId><ArticleId IdType="pmc">PMC7880908</ArticleId><ArticleId IdType="pubmed">33358695</ArticleId></ArticleIdList></Reference><Reference><Citation>Getts D.R., Alanna Spiteri Nicholas J.C., King Stephen D. In: Miller, Chapter 21&#x2014;Microbial Infection as a Trigger of T-Cell Autoimmunity, The Autoimmune Diseases. 6th ed. Noel R., Ian R.M., editors. Academic Press; Cambridge, MA, USA: 2020. pp. 363&#x2013;374.</Citation></Reference><Reference><Citation>Medi&#x107; S., Anastassopoulou C., Lozanov-Crvenkovi&#x107; Z., Vukovi&#x107; V., Dragni&#x107; N., Petrovi&#x107; V., Risti&#x107; M., Pustahija T., Gojkovi&#x107; Z., Tsakris A., et al. Risk and severity of SARS-CoV-2 reinfections during 2020&#x2013;2022 in Vojvodina, Serbia: A population-level observational study. Lancet Reg. Health-Eur. 2022;20:100453. doi: 10.1016/j.lanepe.2022.100453.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.lanepe.2022.100453</ArticleId><ArticleId IdType="pmc">PMC9246704</ArticleId><ArticleId IdType="pubmed">35791336</ArticleId></ArticleIdList></Reference><Reference><Citation>Bowe B., Xie Y., Al-Aly Z. Acute and postacute sequelae associated with SARS-CoV-2 reinfection. Nat. Med. 2022;28:2398&#x2013;2405. doi: 10.1038/s41591-022-02051-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-022-02051-3</ArticleId><ArticleId IdType="pmc">PMC9671810</ArticleId><ArticleId IdType="pubmed">36357676</ArticleId></ArticleIdList></Reference><Reference><Citation>Ma Y., Deng J., Liu Q., Du M., Liu M., Liu J. Long-Term Consequences of Asymptomatic SARS-CoV-2 Infection: A Systematic Review and Meta-Analysis. Int. J. Environ. Res. Public Health. 2023;20:1613. doi: 10.3390/ijerph20021613.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijerph20021613</ArticleId><ArticleId IdType="pmc">PMC9863678</ArticleId><ArticleId IdType="pubmed">36674367</ArticleId></ArticleIdList></Reference><Reference><Citation>Hadley E., Yoo Y.J., Patel S., Zhou A., Laraway B., Wong R., Preiss A., Chew R., Davis H., Chute C.G., et al. N3C and RECOVER consortia. SARS-CoV-2 Reinfection is Preceded by Unique Biomarkers and Related to Initial Infection Timing and Severity: An N3C RECOVER EHR-Based Cohort Study. medRxiv. 2023 doi: 10.1101/2023.01.03.22284042.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2023.01.03.22284042</ArticleId></ArticleIdList></Reference><Reference><Citation>Fern&#xe1;ndez-De-Las-Pe&#xf1;as C., Notarte K.I., Peligro P.J., Velasco J.V., Ocampo M.J., Henry B.M., Arendt-Nielsen L., Torres-Macho J., Plaza-Manzano G. Long-COVID Symptoms in Individuals Infected with Different SARS-CoV-2 Variants of Concern: A Systematic Review of the Literature. Viruses. 2022;14:2629. doi: 10.3390/v14122629.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v14122629</ArticleId><ArticleId IdType="pmc">PMC9785120</ArticleId><ArticleId IdType="pubmed">36560633</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang C., Zhao H., Shannon C.P., Tebbutt S.J. Omicron variants of SARS-CoV-2 and long COVID. Front. Immunol. 2022;13:1061686. doi: 10.3389/fimmu.2022.1061686.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2022.1061686</ArticleId><ArticleId IdType="pmc">PMC9780375</ArticleId><ArticleId IdType="pubmed">36569883</ArticleId></ArticleIdList></Reference><Reference><Citation>Antonelli M., Pujol J.C., Spector T.D., Ourselin S., Steves C.J. Risk of long COVID associated with delta versus omicron variants of SARS-CoV-2. Lancet. 2022;399:2263&#x2013;2264. doi: 10.1016/S0140-6736(22)00941-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(22)00941-2</ArticleId><ArticleId IdType="pmc">PMC9212672</ArticleId><ArticleId IdType="pubmed">35717982</ArticleId></ArticleIdList></Reference><Reference><Citation>Stein C., Nassereldine H., Sorensen R.J.D., O Amlag J., Bisignano C., Byrne S., Castro E., Coberly K., Collins J.K., Dalos J., et al. Past SARS-CoV-2 infection protection against re-infection: A systematic review and meta-analysis. Lancet. 2023;401:833&#x2013;842. doi: 10.1016/S0140-6736(22)02465-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(22)02465-5</ArticleId><ArticleId IdType="pmc">PMC9998097</ArticleId><ArticleId IdType="pubmed">36930674</ArticleId></ArticleIdList></Reference><Reference><Citation>Orend&#xe1;&#x10d;ov&#xe1; M., Kva&#x161;&#x148;&#xe1;k E. Effects of vaccination, new SARS-CoV-2 variants and reinfections on post-COVID-19 complications. Front. Public Health. 2022;10:903568. doi: 10.3389/fpubh.2022.903568.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fpubh.2022.903568</ArticleId><ArticleId IdType="pmc">PMC9372538</ArticleId><ArticleId IdType="pubmed">35968477</ArticleId></ArticleIdList></Reference><Reference><Citation>Byambasuren O., Stehlik P., Clark J., Alcorn K., Glasziou P. Effect of covid-19 vaccination on long covid: Systematic review. BMJ Med. 2023;2:e000385. doi: 10.1136/bmjmed-2022-000385.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjmed-2022-000385</ArticleId><ArticleId IdType="pmc">PMC9978692</ArticleId><ArticleId IdType="pubmed">36936268</ArticleId></ArticleIdList></Reference><Reference><Citation>Tofarides A.G., Christaki E., Milionis H., Nikolopoulos G.K. Effect of Vaccination against SARS-CoV-2 on Long COVID-19: A Narrative Review. Life. 2022;12:2057. doi: 10.3390/life12122057.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/life12122057</ArticleId><ArticleId IdType="pmc">PMC9785763</ArticleId><ArticleId IdType="pubmed">36556422</ArticleId></ArticleIdList></Reference><Reference><Citation>Taquet M., Dercon Q., Harrison P.J. Six-month sequelae of post-vaccination SARS-CoV-2 infection: A retrospective cohort study of 10,024 breakthrough infections. Brain Behav. Immun. 2022;103:154&#x2013;162. doi: 10.1016/j.bbi.2022.04.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbi.2022.04.013</ArticleId><ArticleId IdType="pmc">PMC9013695</ArticleId><ArticleId IdType="pubmed">35447302</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Aly Z., Bowe B., Xie Y. Long COVID after breakthrough SARS-CoV-2 infection. Nat. Med. 2022;28:1461&#x2013;1467. doi: 10.1038/s41591-022-01840-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-022-01840-0</ArticleId><ArticleId IdType="pmc">PMC9307472</ArticleId><ArticleId IdType="pubmed">35614233</ArticleId></ArticleIdList></Reference><Reference><Citation>Ayoubkhani D., Bosworth M.L., King S., Pouwels K.B., Glickman M., Nafilyan V., Zaccardi F., Khunti K., A Alwan N., Walker A.S. Risk of Long COVID in People Infected with Severe Acute Respiratory Syndrome Coronavirus 2 After 2 Doses of a Coronavirus Disease 2019 Vaccine: Community-Based, Matched Cohort Study. Open Forum Infect. Dis. 2022;9:ofac464. doi: 10.1093/ofid/ofac464.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ofid/ofac464</ArticleId><ArticleId IdType="pmc">PMC9494414</ArticleId><ArticleId IdType="pubmed">36168555</ArticleId></ArticleIdList></Reference><Reference><Citation>Notarte K.I., Catahay J.A., Velasco J.V., Pastrana A., Ver A.T., Pangilinan F.C., Peligro P.J., Casimiro M., Guerrero J.J., Gellaco M.M.L., et al. Impact of COVID-19 vaccination on the risk of developing long-COVID and on existing long-COVID symptoms: A systematic review. eClinicalMedicine. 2022;53:101624. doi: 10.1016/j.eclinm.2022.101624.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2022.101624</ArticleId><ArticleId IdType="pmc">PMC9417563</ArticleId><ArticleId IdType="pubmed">36051247</ArticleId></ArticleIdList></Reference><Reference><Citation>Gao P., Liu J., Liu M. Effect of COVID-19 Vaccines on Reducing the Risk of Long COVID in the Real World: A Systematic Review and Meta-Analysis. Int. J. Environ. Res. Public Health. 2022;19:12422. doi: 10.3390/ijerph191912422.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijerph191912422</ArticleId><ArticleId IdType="pmc">PMC9566528</ArticleId><ArticleId IdType="pubmed">36231717</ArticleId></ArticleIdList></Reference><Reference><Citation>Mumtaz A., Sheikh A.A.E., Khan A.M., Khalid S.N., Khan J., Nasrullah A., Sagheer S., Sheikh A.B. COVID-19 Vaccine and Long COVID: A Scoping Review. Life. 2022;12:1066. doi: 10.3390/life12071066.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/life12071066</ArticleId><ArticleId IdType="pmc">PMC9324565</ArticleId><ArticleId IdType="pubmed">35888154</ArticleId></ArticleIdList></Reference><Reference><Citation>Ayoubkhani D., Bermingham C., Pouwels K.B., Glickman M., Nafilyan V., Zaccardi F., Khunti K., A Alwan N., Walker A.S. Trajectory of long covid symptoms after covid-19 vaccination: Community based cohort study. BMJ. 2022;377:e069676. doi: 10.1136/bmj-2021-069676.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj-2021-069676</ArticleId><ArticleId IdType="pmc">PMC9115603</ArticleId><ArticleId IdType="pubmed">35584816</ArticleId></ArticleIdList></Reference><Reference><Citation>Azzolini E., Levi R., Sarti R., Pozzi C., Mollura M., Mantovani A., Rescigno M. Association Between BNT162b2 Vaccination and Long COVID After Infections Not Requiring Hospitalization in Health Care Workers. JAMA. 2022;328:676&#x2013;678. doi: 10.1001/jama.2022.11691.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2022.11691</ArticleId><ArticleId IdType="pmc">PMC9250078</ArticleId><ArticleId IdType="pubmed">35796131</ArticleId></ArticleIdList></Reference><Reference><Citation>Antonelli M., Penfold R.S., Merino J., Sudre C.H., Molteni E., Berry S., Canas L.S., Graham M.S., Klaser K., Modat M., et al. Risk factors and disease profile of post-vaccination SARS-CoV-2 infection in UK users of the COVID Symptom Study app: A prospective, community-based, nested, case-control study. Lancet Infect Dis. 2022;22:43&#x2013;55. doi: 10.1016/S1473-3099(21)00460-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(21)00460-6</ArticleId><ArticleId IdType="pmc">PMC8409907</ArticleId><ArticleId IdType="pubmed">34480857</ArticleId></ArticleIdList></Reference><Reference><Citation>Mizrahi B., Sudry T., Flaks-Manov N., Yehezkelli Y., Kalkstein N., Akiva P., Ekka-Zohar A., Ben David S.S., Lerner U., Bivas-Benita M., et al. Long covid outcomes at one year after mild SARS-CoV-2 infection: Nationwide cohort study. BMJ. 2023;380:e072529. doi: 10.1136/bmj-2022-072529.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj-2022-072529</ArticleId><ArticleId IdType="pmc">PMC9832503</ArticleId><ArticleId IdType="pubmed">36631153</ArticleId></ArticleIdList></Reference><Reference><Citation>Watanabe A., Iwagami M., Yasuhara J., Takagi H., Kuno T. Protective effect of COVID-19 vaccination against long COVID syndrome: A systematic review and meta-analysis. Vaccine. 2023;41:1783&#x2013;1790. doi: 10.1016/j.vaccine.2023.02.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vaccine.2023.02.008</ArticleId><ArticleId IdType="pmc">PMC9905096</ArticleId><ArticleId IdType="pubmed">36774332</ArticleId></ArticleIdList></Reference><Reference><Citation>Slawson D.C. Likelihood of Long COVID Varies by Variant, Sex, and Vaccination Status. Am. Fam. Physic. 2023;107:199.</Citation><ArticleIdList><ArticleId IdType="pubmed">36791431</ArticleId></ArticleIdList></Reference><Reference><Citation>Brannock M.D., Chew R.F., Preiss A.J., Hadley E.C., McMurry J.A., Leese P.J., Girvin A.T., Crosskey M., Zhou A.G., Moffitt R.A., et al. The N3C and RECOVER Consortia. Long COVID Risk and Pre-COVID Vaccination: An EHR-Based Cohort Study from the RECOVER Program. medRxiv. 2022 doi: 10.1101/2022.10.06.22280795.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2022.10.06.22280795</ArticleId><ArticleId IdType="pmc">PMC10201472</ArticleId><ArticleId IdType="pubmed">37217471</ArticleId></ArticleIdList></Reference><Reference><Citation>Nascimento T.C.D.C., Costa L.D.V., Ruiz A.D., Ledo C.B., Fernandes V.P.L., Cardoso L.F., Junior J.M.V., Saretta R., Kalil-Filho R., Drager L.F. Vaccination status and long COVID symptoms in patients discharged from hospital. Sci. Rep. 2023;13:2481. doi: 10.1038/s41598-023-28839-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-023-28839-y</ArticleId><ArticleId IdType="pmc">PMC9922040</ArticleId><ArticleId IdType="pubmed">36774419</ArticleId></ArticleIdList></Reference><Reference><Citation>Pereira S.M., Nugawela M.D., Rojas N.K., Shafran R., McOwat K., Simmons R., Ford T., Heyman I., Ladhani S.N., Cheung E.Y., et al. Post-COVID-19 condition at 6 months and COVID-19 vaccination in non-hospitalised children and young people. Arch. Dis. Child. 2023;108:289&#x2013;295.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10086284</ArticleId><ArticleId IdType="pubmed">36599625</ArticleId></ArticleIdList></Reference><Reference><Citation>Tran V.-T., Perrodeau E., Saldanha J., Pane I., Ravaud P. Efficacy of first dose of covid-19 vaccine versus no vaccination on symptoms ofpatientswith long covid: Target trial emulation based on ComPaRe e-cohort. BMJ Med. 2023;2:e000229. doi: 10.1136/bmjmed-2022-000229.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjmed-2022-000229</ArticleId><ArticleId IdType="pmc">PMC9978748</ArticleId><ArticleId IdType="pubmed">36910458</ArticleId></ArticleIdList></Reference><Reference><Citation>Kahlert C.R., Strahm C., G&#xfc;sewell S., Cusini A., Brucher A., Goppel S., M&#xf6;ller E., M&#xf6;ller J.C., Ortner M., Ruetti M., et al. Post-Acute Sequelae After Severe Acute Respiratory Syndrome Coronavirus 2 Infection by Viral Variant and Vaccination Status: A Multicenter Cross-Sectional Study. Clin. Infect. Dis. 2023;77:194&#x2013;202. doi: 10.1093/cid/ciad143.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciad143</ArticleId><ArticleId IdType="pmc">PMC10371307</ArticleId><ArticleId IdType="pubmed">36905145</ArticleId></ArticleIdList></Reference><Reference><Citation>Catal&#xe0; M., Mercad&#xe9;-Besora N., Kolde R., Trinh N.T., Roel E., Burn E., Rathod-Mistry T., Kostka K., Man W.Y., Delmestri A., et al.  The Effectiveness of COVID-19 Vaccines to Prevent Long COVID Symptoms: Staggered Cohort Analyses of Data from the UK, Spain, and Estonia.  [(accessed on 14 June 2023)].  Available online:  https://ssrn.com/abstract=4474215.</Citation><ArticleIdList><ArticleId IdType="pubmed">38219763</ArticleId></ArticleIdList></Reference><Reference><Citation>Anastassopoulou C., Gkizarioti Z., Patrinos G.P., Tsakris A. Human genetic factors associated with susceptibility to SARS-CoV-2 infection and COVID-19 disease severity. Hum. Genom. 2020;14:40. doi: 10.1186/s40246-020-00290-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40246-020-00290-4</ArticleId><ArticleId IdType="pmc">PMC7578581</ArticleId><ArticleId IdType="pubmed">33092637</ArticleId></ArticleIdList></Reference><Reference><Citation>Anastassopoulou C., Spanakis N., Tsakris A. SARS-CoV-2 transmission, the ambiguous role of children and considerations for the reopening of schools in the fall. Futur. Microbiol. 2020;15:1201&#x2013;1206. doi: 10.2217/fmb-2020-0195.</Citation><ArticleIdList><ArticleId IdType="doi">10.2217/fmb-2020-0195</ArticleId><ArticleId IdType="pmc">PMC7469891</ArticleId><ArticleId IdType="pubmed">32878481</ArticleId></ArticleIdList></Reference><Reference><Citation>Chou J., Thomas P.G., Randolph A.G. Immunology of SARS-CoV-2 infection in children. Nat. Immunol. 2022;23:177&#x2013;185. doi: 10.1038/s41590-021-01123-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41590-021-01123-9</ArticleId><ArticleId IdType="pmc">PMC8981222</ArticleId><ArticleId IdType="pubmed">35105983</ArticleId></ArticleIdList></Reference><Reference><Citation>Medi&#x107; S., Anastassopoulou C., Lozanov-Crvenkovi&#x107; Z., Dragni&#x107; N., Petrovi&#x107; V., Risti&#x107; M., Pustahija T., Tsakris A., Ioannidis J.P.A. Incidence, Risk, and Severity of SARS-CoV-2 Reinfections in Children and Adolescents between March 2020 and July 2022 in Serbia. JAMA Netw. Open. 2023;6:e2255779. doi: 10.1001/jamanetworkopen.2022.55779.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2022.55779</ArticleId><ArticleId IdType="pmc">PMC9926322</ArticleId><ArticleId IdType="pubmed">36780157</ArticleId></ArticleIdList></Reference><Reference><Citation>Lopez-Leon S., Wegman-Ostrosky T., del Valle N.C.A., Perelman C., Sepulveda R., Rebolledo P.A., Cuapio A., Villapol S. Long-COVID in children and adolescents: A systematic review and meta-analyses. Sci. Rep. 2022;12:9950. doi: 10.1038/s41598-022-13495-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-022-13495-5</ArticleId><ArticleId IdType="pmc">PMC9226045</ArticleId><ArticleId IdType="pubmed">35739136</ArticleId></ArticleIdList></Reference><Reference><Citation>Fainardi V., Meoli A., Chiopris G., Motta M., Skenderaj K., Grandinetti R., Bergomi A., Antodaro F., Zona S., Esposito S. Long COVID in Children and Adolescents. Life. 2022;12:285. doi: 10.3390/life12020285.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/life12020285</ArticleId><ArticleId IdType="pmc">PMC8876679</ArticleId><ArticleId IdType="pubmed">35207572</ArticleId></ArticleIdList></Reference><Reference><Citation>Morello R., Martino L., Buonsenso D. Diagnosis and management of post-COVID (Long COVID) in children: A moving target. Curr. Opin. Pediatr. 2023;35:184&#x2013;192. doi: 10.1097/MOP.0000000000001221.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MOP.0000000000001221</ArticleId><ArticleId IdType="pmc">PMC9994801</ArticleId><ArticleId IdType="pubmed">36660968</ArticleId></ArticleIdList></Reference><Reference><Citation>Izquierdo-Pujol J., Moron-Lopez S., Dalmau J., Gonzalez-Aumatell A., Carreras-Abad C., Mendez M., Rodrigo C., Martinez-Picado J. Post COVID-19 Condition in Children and Adolescents: An Emerging Problem. Front. Pediatr. 2022;10:894204. doi: 10.3389/fped.2022.894204.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fped.2022.894204</ArticleId><ArticleId IdType="pmc">PMC9130634</ArticleId><ArticleId IdType="pubmed">35633949</ArticleId></ArticleIdList></Reference><Reference><Citation>Funk A.L., Kuppermann N., Florin T.A., Tancredi D.J., Xie J., Kim K., Finkelstein Y., Neuman M.I., Salvadori M.I., Yock-Corrales A., et al. Post&#x2013;COVID-19 Conditions Among Children 90 Days After SARS-CoV-2 Infection. JAMA Netw. Open. 2022;5:e2223253. doi: 10.1001/jamanetworkopen.2022.23253.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2022.23253</ArticleId><ArticleId IdType="pmc">PMC9308058</ArticleId><ArticleId IdType="pubmed">35867061</ArticleId></ArticleIdList></Reference><Reference><Citation>Berg S.K., Palm P., Nygaard U., Bundgaard H., Petersen M.N.S., Rosenkilde S., Thorsted A.B., Ersb&#xf8;ll A.K., Thygesen L.C., Nielsen S.D., et al. Long COVID symptoms in SARS-CoV-2-positive children aged 0&#x2013;14 years and matched controls in Denmark (LongCOVIDKidsDK): A national, cross-sectional study. Lancet Child Adolesc. Health. 2022;6:614&#x2013;623. doi: 10.1016/S2352-4642(22)00154-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2352-4642(22)00154-7</ArticleId><ArticleId IdType="pmc">PMC9221683</ArticleId><ArticleId IdType="pubmed">35752194</ArticleId></ArticleIdList></Reference><Reference><Citation>Buonsenso D., Munblit D., Pazukhina E., Ricchiuto A., Sinatti D., Zona M., De Matteis A., D&#x2019;ilario F., Gentili C., Lanni R., et al. Post-COVID Condition in Adults and Children Living in the Same Household in Italy: A Prospective Cohort Study Using the ISARIC Global Follow-Up Protocol. Front. Pediatr. 2022;10:834875. doi: 10.3389/fped.2022.834875.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fped.2022.834875</ArticleId><ArticleId IdType="pmc">PMC9070551</ArticleId><ArticleId IdType="pubmed">35529336</ArticleId></ArticleIdList></Reference><Reference><Citation>Woodrow M., Carey C., Ziauddeen N., Thomas R., Akrami A., Lutje V., Greenwood D.C., Alwan N.A. Systematic review of the prevalence of Long COVID. medRxiv. 2022 doi: 10.1093/ofid/ofad233.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ofid/ofad233</ArticleId><ArticleId IdType="pmc">PMC10316694</ArticleId><ArticleId IdType="pubmed">37404951</ArticleId></ArticleIdList></Reference><Reference><Citation>Zheng Y.-B., Zeng N., Yuan K., Tian S.-S., Yang Y.-B., Gao N., Chen X., Zhang A.-Y., Kondratiuk A.L., Shi P.-P., et al. Prevalence and risk factor for long COVID in children and adolescents: A meta-analysis and systematic review. J. Infect. Public Health. 2023;16:660&#x2013;672. doi: 10.1016/j.jiph.2023.03.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jiph.2023.03.005</ArticleId><ArticleId IdType="pmc">PMC9990879</ArticleId><ArticleId IdType="pubmed">36931142</ArticleId></ArticleIdList></Reference><Reference><Citation>Warren-Gash C., Lacey A., Cook S., Stocker D., Toon S., Lelii F., Ford B., Ireland G., Ladhani S.N., Stephenson T., et al. Post-COVID-19 condition and persisting symptoms in English schoolchildren: Repeated surveys to March 2022. BMC Infect. Dis. 2023;23:201. doi: 10.1186/s12879-023-08203-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12879-023-08203-1</ArticleId><ArticleId IdType="pmc">PMC10075149</ArticleId><ArticleId IdType="pubmed">37020190</ArticleId></ArticleIdList></Reference><Reference><Citation>Borch L., Holm M., Knudsen M., Ellermann-Eriksen S., Hagstroem S. Long COVID symptoms and duration in SARS-CoV-2 positive children&#x2014;A nationwide cohort study. Eur. J. Pediatr. 2022;181:1597&#x2013;1607. doi: 10.1007/s00431-021-04345-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00431-021-04345-z</ArticleId><ArticleId IdType="pmc">PMC8742700</ArticleId><ArticleId IdType="pubmed">35000003</ArticleId></ArticleIdList></Reference><Reference><Citation>Stephenson T., Shafran R., Ladhani S.N. Long COVID in children and adolescents. Curr. Opin. Infect. Dis. 2022;35:461&#x2013;467. doi: 10.1097/QCO.0000000000000854.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/QCO.0000000000000854</ArticleId><ArticleId IdType="pmc">PMC9553244</ArticleId><ArticleId IdType="pubmed">36098262</ArticleId></ArticleIdList></Reference><Reference><Citation>Hossain M.M., Nesa F., Das J., Aggad R., Tasnim S., Bairwa M., Ma P., Ramirez G. Global burden of mental health problems among children and adolescents during COVID-19 pandemic: An umbrella review. Psychiatry Res. 2022;317:114814. doi: 10.1016/j.psychres.2022.114814.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.psychres.2022.114814</ArticleId><ArticleId IdType="pmc">PMC9420079</ArticleId><ArticleId IdType="pubmed">36055064</ArticleId></ArticleIdList></Reference><Reference><Citation>Shachar-Lavie I., Shorer M., Segal H., Fennig S., Ashkenazi-Hoffnung L. Mental health among children with long COVID during the COVID-19 pandemic. Eur. J. Pediatr. 2023;182:1793&#x2013;1801. doi: 10.1007/s00431-023-04854-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00431-023-04854-z</ArticleId><ArticleId IdType="pmc">PMC9925927</ArticleId><ArticleId IdType="pubmed">36786887</ArticleId></ArticleIdList></Reference><Reference><Citation>Miller F., Nguyen V., Navaratnam A.M., Shrotri M., Kovar J., Hayward A.C., Fragaszy E., Aldridge R.W., Hardelid P. Prevalence and Characteristics of Persistent Symptoms in Children During the COVID-19 Pandemic: Evidence from a Household Cohort Study in England and Wales. Pediatr. Infect. Dis. J. 2022;41:979&#x2013;984. doi: 10.1097/INF.0000000000003715.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/INF.0000000000003715</ArticleId><ArticleId IdType="pmc">PMC9645448</ArticleId><ArticleId IdType="pubmed">36375098</ArticleId></ArticleIdList></Reference><Reference><Citation>Dumont R., Richard V., Lorthe E., Loizeau A., Pennacchio F., Zaballa M.-E., Baysson H., Nehme M., Perrin A., L&#x2019;huillier A.G., et al. A population-based serological study of post-COVID syndrome prevalence and risk factors in children and adolescents. Nat. Commun. 2022;13:7086. doi: 10.1038/s41467-022-34616-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-022-34616-8</ArticleId><ArticleId IdType="pmc">PMC9708639</ArticleId><ArticleId IdType="pubmed">36446760</ArticleId></ArticleIdList></Reference><Reference><Citation>Adler L., Israel M., Yehoshua I., Azuri J., Hoffman R., Shahar A., Reuveni M.M., Grossman Z. Long COVID symptoms in Israeli children with and without a history of SARS-CoV-2 infection: A cross-sectional study. BMJ Open. 2023;13:e064155. doi: 10.1136/bmjopen-2022-064155.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjopen-2022-064155</ArticleId><ArticleId IdType="pmc">PMC9944622</ArticleId><ArticleId IdType="pubmed">36810170</ArticleId></ArticleIdList></Reference><Reference><Citation>Haddad A., Janda A., Renk H., Stich M., Frieh P., Kaier K., Lohrmann F., Nieters A., Willems A., Huzly D., et al. Long COVID symptoms in exposed and infected children, adolescents and their parents one year after SARS-CoV-2 infection: A prospective observational cohort study. Ebiomedicine. 2022;84:104245. doi: 10.1016/j.ebiom.2022.104245.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ebiom.2022.104245</ArticleId><ArticleId IdType="pmc">PMC9495281</ArticleId><ArticleId IdType="pubmed">36155957</ArticleId></ArticleIdList></Reference><Reference><Citation>Bechmann N., Barthel A., Schedl A., Herzig S., Varga Z., Gebhard C., Mayr M., Hantel C., Beuschlein F., Wolfrum C., et al. Sexual dimorphism in COVID-19: Potential clinical and public health implications. Lancet Diabetes Endocrinol. 2022;10:221&#x2013;230. doi: 10.1016/S2213-8587(21)00346-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-8587(21)00346-6</ArticleId><ArticleId IdType="pmc">PMC8803381</ArticleId><ArticleId IdType="pubmed">35114136</ArticleId></ArticleIdList></Reference><Reference><Citation>Seery V., Raiden S., Penedo J.M.G., Borda M., Herrera L., Uranga M., del Pont M.M., Chirino C., Erramuspe C., Alvarez L.S., et al. Persistent symptoms after COVID-19 in children and adolescents from Argentina. Int. J. Infect. Dis. 2023;129:49&#x2013;56. doi: 10.1016/j.ijid.2023.01.031.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijid.2023.01.031</ArticleId><ArticleId IdType="pmc">PMC9892252</ArticleId><ArticleId IdType="pubmed">36736574</ArticleId></ArticleIdList></Reference><Reference><Citation>Kumar P., Jat K.R. Post-COVID-19 Sequelae in Children. Indian J. Pediatr. 2023;90:605&#x2013;611. doi: 10.1007/s12098-023-04473-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12098-023-04473-4</ArticleId><ArticleId IdType="pmc">PMC9992903</ArticleId><ArticleId IdType="pubmed">36884145</ArticleId></ArticleIdList></Reference><Reference><Citation>Jarnig G., Kerbl R., van Poppel M.N.M. Changes in Children&#x2019;s Fitness and Health Status Over the Course of the COVID-19 Pandemic: A 34-month Longitudinal Study of 331 Primary School Children (September 2019 to June 2022) medRxiv. 2022 September 20; doi: 10.1101/2022.12.01.22282992.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2022.12.01.22282992</ArticleId><ArticleId IdType="pmc">PMC10884133</ArticleId><ArticleId IdType="pubmed">38008789</ArticleId></ArticleIdList></Reference><Reference><Citation>Balderas L.M.d.C.J., Fern&#xe1;ndez A.N., Garza S.A.D., Jerves M.I.O., Figueroa W.E.S., Koretzky S.G., Gonz&#xe1;lez H.M., Kl&#xfc;nder M.K., Espinosa J.G., Zerme&#xf1;o J.N., et al. Long COVID in children and adolescents: COVID-19 follow-up results in third-level pediatric hospital. Front. Pediatr. 2023;11:1016394. doi: 10.3389/fped.2023.1016394.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fped.2023.1016394</ArticleId><ArticleId IdType="pmc">PMC9922986</ArticleId><ArticleId IdType="pubmed">36793333</ArticleId></ArticleIdList></Reference><Reference><Citation>Garazzino S., Denina M., Pruccoli G., Funiciello E., Ramenghi U., Fagioli F. Long COVID-19/post-COVID condition in children: Do we all speak the same language? Ital. J. Pediatr. 2023;49:12. doi: 10.1186/s13052-023-01417-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13052-023-01417-8</ArticleId><ArticleId IdType="pmc">PMC9859668</ArticleId><ArticleId IdType="pubmed">36670478</ArticleId></ArticleIdList></Reference><Reference><Citation>Marshall M. Long COVID: Answers emerge on how many people get better. Nature. 2023;619:20. doi: 10.1038/d41586-023-02121-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/d41586-023-02121-7</ArticleId><ArticleId IdType="pubmed">37369791</ArticleId></ArticleIdList></Reference><Reference><Citation>Xie Y., Choi T., Al-Aly Z. Association of Treatment with Nirmatrelvir and the Risk of Post&#x2013;COVID-19 Condition. JAMA Intern. Med. 2023;183:554&#x2013;564. doi: 10.1001/jamainternmed.2023.0743.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamainternmed.2023.0743</ArticleId><ArticleId IdType="pmc">PMC10037200</ArticleId><ArticleId IdType="pubmed">36951829</ArticleId></ArticleIdList></Reference><Reference><Citation>Bramante C.T., Buse J.B., Liebovitz D.M., Nicklas J.M., A Puskarich M., Cohen K., Belani H.K., Anderson B.J., Huling J.D., Tignanelli C.J., et al. Outpatient treatment of COVID-19 and incidence of post-COVID-19 condition over 10 months (COVID-OUT): A multicentre, randomised, quadruple-blind, parallel-group, phase 3 trial. Lancet Infect. Dis. 2023:S1473-3099(23)00299-2. doi: 10.1016/S1473-3099(23)00299-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(23)00299-2</ArticleId><ArticleId IdType="pmc">PMC11259948</ArticleId><ArticleId IdType="pubmed">37302406</ArticleId></ArticleIdList></Reference><Reference><Citation>Anastassopoulou C., Hatziantoniou S., Boufidou F., Patrinos G.P., Tsakris A. The Role of Oral Antivirals for COVID-19 Treatment in Shaping the Pandemic Landscape. J. Pers. Med. 2022;12:439. doi: 10.3390/jpm12030439.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jpm12030439</ArticleId><ArticleId IdType="pmc">PMC8953396</ArticleId><ArticleId IdType="pubmed">35330439</ArticleId></ArticleIdList></Reference><Reference><Citation>Stergiou K.D., Minopoulos G.M., Memos V.A., Stergiou C.L., Koidou M.P., Psannis K.E. A Machine Learning-Based Model for Epidemic Forecasting and Faster Drug Discovery. Appl. Sci. 2022;12:10766. doi: 10.3390/app122110766.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/app122110766</ArticleId></ArticleIdList></Reference><Reference><Citation>Pfaff E.R., Girvin A.T., Bennett T.D., Bhatia A., Brooks I.M., Deer R.R., Dekermanjian J.P., Jolley S.E., Kahn M.G., Kostka K., et al. Identifying who has long COVID in the USA: A machine learning approach using N3C data. Lancet Digit. Health. 2022;4:e532&#x2013;e541. doi: 10.1016/S2589-7500(22)00048-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2589-7500(22)00048-6</ArticleId><ArticleId IdType="pmc">PMC9110014</ArticleId><ArticleId IdType="pubmed">35589549</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>